Showing results (421-430 of 5,925) with videos related to
Sort By:
Pageof 593
The Prostate|August 1, 1995
Purification of estramustine-binding protein and production of monoclonal antibodies to its different componentsP Björk, F Donn, C Glad, et al.The Prostate|January 1, 1993
Suppression of plasma testosterone and prostate carcinoma size by a redox-based, brain-targeted estrogen delivery system in the ratM H Rahimy, N Bodor, J W SimpkinsThe Prostate|July 1, 1995
Tumor suppressor gene p53 mutations in human prostate cancerY Kubota, T Shuin, H Uemura, et al.The Prostate|July 1, 1995
Time course of reactive oxygen intermediates release and histopathological findings during experimental autoimmune prostatitis developmentM A Orsilles, A C Donadio, M Depiante-DepaoliThe Prostate|October 1, 1995
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma modelB L Neubauer, K L Best, D F Counts, et al.The Prostate|November 1, 1995
Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatismJ L Bosch, W C Hop, C H Bangma, et al.The Prostate|November 1, 1995
Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrowS H Lang, W R Miller, F K HabibThe Prostate|January 1, 1993
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaPE G Langeler, C J van Uffelen, M A Blankenstein, et al.The Prostate|January 1, 1993
Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged menS Holmäng, P Mårin, G Lindstedt, et al.The Prostate|January 1, 1984
Carcinoma of the prostate in Israel: some epidemiological and therapeutic considerationsC Servadio, E Mukamel, E KahanPageof 593